AMLODIPINE BESYLATE

Product NDC
71610-830
11-digit product format
716100830
Labeler code
71610
Product ID
71610-830_29b99df4-d06a-8ad8-e063-6294a90a2ff4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
AMLODIPINE BESYLATE
Dosage form
TABLET
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA078414
Marketing category
ANDA
Marketing start
2021-10-01
Substance
AMLODIPINE BESYLATE
Active strength
10 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
864V2Q084HAMLODIPINE BESYLATE111470-99-6AMLODIPINE BESYLATE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71610-830-307161008303030 TABLET in 1 BOTTLE (71610-830-30) 30 tablet2024-05-13NoNoHistorical
71610-830-457161008304545 TABLET in 1 BOTTLE (71610-830-45) 45 tablet2024-05-13NoNoHistorical
71610-830-607161008306090 TABLET in 1 BOTTLE (71610-830-60) 90 tablet2024-12-19NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
AMLODIPINE BESYLATE 10 mgAphena Pharma Solutions - Tennessee, LLC2024-12-20HUMAN PRESCRIPTION DRUG LABEL2